Price
CHART BY
Frequently asked questions
What is the Earnings Per Share (EPS) for DermTech?
DermTech's Earnings Per Share (EPS) over the trailing twelve months (TTM) is -2.686. EPS indicates the company's profitability on a per-share basis.
What are the analyst ratings and target price for DermTech's stock?
Currently, 1 analysts cover DermTech's stock, with a consensus target price of $1.50. Analyst ratings provide insights into the stock's expected performance.
What is DermTech's revenue over the trailing twelve months?
Over the trailing twelve months, DermTech reported a revenue of $15.66M.
What is the EBITDA for DermTech?
DermTech's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is -$85.32M. EBITDA measures the company's overall financial performance.
What is the free cash flow of DermTech?
DermTech has a free cash flow of -$72.21M. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.
How many employees does DermTech have, and what sector and industry does it belong to?
DermTech employs approximately 208 people. It operates in the Health Care sector, specifically within the Medical Specialties industry.
Financials
- EPS (TTM)
- -2.686
- Revenue (TTM)
- $15.66M
- EBITDA (TTM)
- -$85.32M
- Free Cashflow (TTM)
- -$72.21M
Analyst Ratings
The price target is $1.50 and the stock is covered by 1 analysts.
Buy
0
Hold
1
Sell
0
Information
DermTech, Inc. engages in the development and sale of products for the diagnosis and treatment of skin diseases. It markets and develops products that facilitate diagnosis and management of various skin conditions, including skin cancer, inflammatory diseases, and aging-related conditions. Its products and services include melanoma test, smart sticker, and telemedicine option for melanoma test. The company was founded in 1995 and is headquartered in San Diego, CA.
- Employees
- 208
- Industries
- Medical Specialties
- Sector
- Health Care
Identifier
- Primary Ticker
- DMTK
Knockouts
Real-time data from LSX · Fundamentals & EOD data from FactSet